Skip to main content
OpenTrials
Completed

NCT Number: NCT00696527

National Survey on Infiltrative Breast Cancer

The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infiltrative Breast Cancer

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Research Site, Aix-en-Provence, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women> or = 18 years old
  • Women with newly diagnosis of infiltrative breast cancer
  • Agree to take part in this study

Exclusion criteria

  • Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma)
  • Women with in situ ductal carcinoma or in situ lobular carcinoma

Treatment and study plan

Primary outcomes

  1. Radiological, Clinical and Histological characteristics

    Time frame: Once

Secondary outcomes

  1. Treatments: Surgery, radiotherapy, chemotherapy, hormonotherapy.

    Time frame: Once

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer

Acronym: CSI

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Jun 12, 2008
Registry last updated
Dec 10, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.